New Jersey
Pharmaceutical Giants Bristol Myers Squibb and Kyowa Kirin Announce 119 Layoffs in New Jersey Amid Restructuring Efforts
Bristol Myers Squibb, Kyowa Kirin, layoffs, New Jersey, restructuring, pharmaceutical industry, cost-cutting, workforce reduction
Novartis Announces 139 Layoffs in New Jersey Amid Ongoing Restructuring Efforts
Novartis, layoffs, New Jersey, restructuring, pharmaceutical industry
Novartis Announces 139 Job Cuts in New Jersey Amid Commercial Refocus
Novartis, job cuts, New Jersey, commercial refocus, restructuring
Bristol Myers Squibb Announces Additional Layoffs in New Jersey Amid Cost-Cutting Efforts
Bristol Myers Squibb, layoffs, New Jersey, cost-cutting, pharmaceutical industry
Pharmaceutical Giants J&J and Bayer Announce Layoffs of Nearly 300 Employees in New Jersey
Johnson & Johnson, Bayer, layoffs, New Jersey, pharmaceutical industry, job cuts
Big Pharma’s Layoff Wave Continues in New Jersey: J&J and Bayer Announce Significant Job Cuts
Big Pharma layoffs, New Jersey, Johnson & Johnson, Bayer, pharmaceutical industry restructuring
Bristol Myers Squibb Continues Layoffs, Cutting 79 More Jobs in New Jersey Amid $1.5B Cost Reduction Effort
Bristol Myers Squibb, layoffs, New Jersey, cost reduction, pharmaceutical industry
BeiGene CEO Eyes Biologics Deals for New US Innovation Center in New Jersey
BeiGene, biologics, innovation center, New Jersey, deals, CEO, John Oyler
Bristol Myers Squibb to Cut Over 860 Jobs in New Jersey as Part of $1.5 Billion Savings Campaign
Bristol Myers Squibb, job cuts, New Jersey, $1.5 billion savings campaign, cost savings, pharmaceutical industry